Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
NeuroMetrix reports agreement with GSK Healthcare on 2019 Quell joint development program
Intra-Cellular Therapies announced favorable results from the second part of its open-label safety switching study (303) assessing the effects of long-term administration of lumateperone in patients with stable symptoms of schizophrenia.
December 11, 2018
More...
Email This Page
to a Friend
Print This
Page